Caris Life Sciences (CAI) Amortizatization of Intangibles (2024 - 2026)
Caris Life Sciences (CAI) recorded quarterly Amortizatization of Intangibles of $1.3 million in Q1 2026, down 84.33% quarter-over-quarter from $8.4 million in Q4 2025, and down 31.98% on a YoY basis from $1.9 million in Q1 2025.
Caris Life Sciences (CAI) Amortizatization of Intangibles (2024 - 2026) Analysis & Trends
Caris Life Sciences' Amortizatization of Intangibles history runs 3 years deep, the most recent figure standing at $1.3 million for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles fell 31.98% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $20.0 million (up 169.75% YoY), while the FY2025 annual figure was $12.8 million, up 81.0% from the prior year.
- Amortizatization of Intangibles was $1.3 million for Q1 2026 at Caris Life Sciences, down from $8.4 million in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $8.4 million in Q4 2025 to a low of $1.3 million in Q1 2026.
- Historically, Amortizatization of Intangibles has averaged $3.4 million across 3 years, with a median of $1.9 million in 2024.
- The sharpest annual moves came in 2025 and 2026: Amortizatization of Intangibles surged 348.01% in 2025, then plunged 31.98% in 2026.
- A 3-year view of Amortizatization of Intangibles shows it stood at $1.9 million in 2024, then soared by 343.07% to $8.4 million in 2025, then sank by 84.33% to $1.3 million in 2026.
- The last three Amortizatization of Intangibles figures came in at $1.3 million (Q1 2026), $8.4 million (Q4 2025), and $2.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Caris Life Sciences | 5.22 Bn | 4.40 Bn | 171.13 Mn | 1.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.32 Mn |
| Mar 31, 2026 | 1.32 Mn |
| Dec 31, 2025 | 8.45 Mn |
| Dec 31, 2025 | 8.45 Mn |
| Sep 30, 2025 | 2.46 Mn |
| Sep 30, 2025 | 2.46 Mn |
| Jun 30, 2025 | 7.76 Mn |
| Jun 30, 2025 | 7.76 Mn |
| Mar 31, 2025 | 1.95 Mn |
| Mar 31, 2025 | 1.95 Mn |
| Dec 31, 2024 | 1.91 Mn |
| Dec 31, 2024 | 1.91 Mn |
| Sep 30, 2024 | 1.83 Mn |
| Sep 30, 2024 | 1.83 Mn |
| Jun 30, 2024 | 1.73 Mn |
| Jun 30, 2024 | 1.73 Mn |